ECG morphological variability in beat space for risk stratification after acute coronary syndrome.

PubWeight™: 0.83‹?›

🔗 View Article (PMC 4309066)

Published in J Am Heart Assoc on June 24, 2014

Authors

Yun Liu1, Zeeshan Syed2, Benjamin M Scirica3, David A Morrow3, John V Guttag4, Collin M Stultz5

Author Affiliations

1: Institute for Medical Engineering and Sciences, Massachusetts Institute of Technology and Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA (Y.L., C.M.S.).
2: Electrical and Computer Engineering, University of Michigan, Ann Arbor, MI (Z.S.).
3: TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (B.M.S., D.A.M.).
4: MIT Department of Electrical Engineering and Computer Science, Cambridge, MA (J.V.G., C.M.S.).
5: Institute for Medical Engineering and Sciences, Massachusetts Institute of Technology and Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA (Y.L., C.M.S.) MIT Department of Electrical Engineering and Computer Science, Cambridge, MA (J.V.G., C.M.S.).

Articles cited by this

PhysioBank, PhysioToolkit, and PhysioNet: components of a new research resource for complex physiologic signals. Circulation (2000) 21.03

Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J (1996) 16.86

Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med (2010) 14.49

The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. JAMA (2000) 12.86

Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet (1998) 9.29

Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med (2003) 7.25

The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med (2001) 5.50

Statistical evaluation of prognostic versus diagnostic models: beyond the ROC curve. Clin Chem (2007) 5.23

Receiver-operating characteristic analysis for evaluating diagnostic tests and predictive models. Circulation (2007) 4.58

Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction. Lancet (1999) 3.38

Heart rate variability: measurement and clinical utility. Ann Noninvasive Electrocardiol (2005) 3.15

Microvolt T-wave alternans physiological basis, methods of measurement, and clinical utility--consensus guideline by International Society for Holter and Noninvasive Electrocardiology. J Am Coll Cardiol (2011) 3.00

Deceleration capacity of heart rate as a predictor of mortality after myocardial infarction: cohort study. Lancet (2006) 2.75

Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non ST-segment elevation acute coronary syndrome: results from the Metabolic Efficiency With Ranolazine for Less Ischemia in Non ST-Elevation Acute Coronary Syndrome Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trial. Circulation (2007) 2.64

Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial. JAMA (2007) 2.57

Beat-to-beat QT interval variability: novel evidence for repolarization lability in ischemic and nonischemic dilated cardiomyopathy. Circulation (1997) 2.53

Automatic classification of heartbeats using ECG morphology and heartbeat interval features. IEEE Trans Biomed Eng (2004) 2.35

Safety, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non-ST-segment elevation acute coronary syndrome: primary results of the DISPERSE-2 trial. J Am Coll Cardiol (2007) 2.01

Risk stratification after acute myocardial infarction by heart rate turbulence. Circulation (2003) 1.96

Robust heart rate estimation from multiple asynchronous noisy sources using signal quality indices and a Kalman filter. Physiol Meas (2007) 1.84

Sudden cardiac death risk stratification in patients with nonischemic dilated cardiomyopathy. J Am Coll Cardiol (2014) 1.80

Modified moving average analysis of T-wave alternans to predict ventricular fibrillation with high accuracy. J Appl Physiol (1985) (2002) 1.79

Comparing spectra of a series of point events particularly for heart rate variability data. IEEE Trans Biomed Eng (1984) 1.59

Prediction of sudden cardiac death in patients after acute myocardial infarction using T-wave alternans: a prospective study. J Electrocardiol (2011) 1.47

Heart rate variability and myocardial infarction: systematic literature review and metanalysis. Eur Rev Med Pharmacol Sci (2009) 1.39

Improved Stratification of Autonomic Regulation for risk prediction in post-infarction patients with preserved left ventricular function (ISAR-Risk). Eur Heart J (2008) 1.37

Novel measures of heart rate variability predict cardiovascular mortality in older adults independent of traditional cardiovascular risk factors: the Cardiovascular Health Study (CHS). J Cardiovasc Electrophysiol (2008) 1.14

Atrial infarction of the heart. Circulation (1961) 1.12

Evaluation of a novel anti-ischemic agent in acute coronary syndromes: design and rationale for the Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-elevation acute coronary syndromes (MERLIN)-TIMI 36 trial. Am Heart J (2006) 1.05

Alternating morphology of the QRST complex preceding sudden death. N Engl J Med (1992) 0.87

Relation of death within 90 days of non-ST-elevation acute coronary syndromes to variability in electrocardiographic morphology. Am J Cardiol (2008) 0.83

Computationally generated cardiac biomarkers for risk stratification after acute coronary syndrome. Sci Transl Med (2011) 0.82

The Beatquency Domain: an unusual application of the fast Fourier transform. IEEE Trans Biomed Eng (1977) 0.80

Spectral energy of ECG morphologic differences to predict death. Cardiovasc Eng (2009) 0.78

ECG manifestations of myocardial ischemia. Arch Intern Med (1980) 0.77

Beat-to-beat electrocardiographic morphology variation in healed myocardial infarction. Am J Cardiol (1991) 0.77